CT 327 in the "Atopy Patch Test" Model

NCT01368315 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision

Conditions

Atopic Dermatitis

Interventions

DRUG: CT327 application
DRUG: Placebo
DRUG: Active comparator
DRUG: No intervention

Sponsor

Creabilis SA